솔루션
리소스
회사 소개
문의하기
로그인
회원가입
Why drug development needs a new kind of software - and what Cheiron is building.
July 23, 2026
September 01, 2026
Two independent security milestones validate the controls protecting customer data across Cheiron’s AI-native platform for drug development.
We're announcing Cheiron's $8M seed round, led by Menlo Ventures.
We're announcing Cheiron's $8M seed round, led by Menlo Ventures, to build the first AI-native operating system for drug programs.
AI-Native OS for Lifesciences
© 2026 PhnyX Lab Inc. All rights reserved.
Cheiron
회사
케이론 소개
채용
블로그
기타
도움말 센터
개인정보 처리방침
이용약관
